Many working-age Americans struggle to pay for the heart medications that protect them from heart attack, stroke and heart disease, a new study reports.
About one in eight adults suffering from a high-risk heart problem say financial strain has caused them to skip taking their meds, delay filling a prescription, or take a lower dose than prescribed, the researchers said.
Emergency room visits for high blood pressure surged following last year's recall of the popular heart drug valsartan, Canadian researchers report.
Within the first month of the recall, there was a 55% increase of people coming to Ontario-area emergency departments complaining of high blood pressure, said lead researcher Cynthia Jackevicius. She is a senior scientist with the Inst...
Forget doctor's instructions: New research shows a smartphone app is the best way to get heart patients to remember to take their medicines.
Heart attack survivors are typically prescribed medications to prevent another attack, but one in four stop taking at least one drug within 30 days after leaving the hospital. That increases the chance of re-hospitalization and premature death.<...
As Jara Herron walked down her hallway to feed her 10-day-old baby, she didn't feel right. She was nauseous. Her chest felt like elephants were sitting on it. Then Herron tried to pick up her baby and couldn't. Her right arm went numb and she could barely breathe.
Her husband dialed 911.
When paramedics arrived, they told Herron's husband she was having some sort of "heart...
Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk.
Bleeding is a common and potentially dangerous side effect of current anti-clotting drugs used to treat stroke patients. But the new findings suggest that the antiplatelet drug, called ACT017, may be a safe and effective alternative to current t...
More than a quarter of people who could benefit from taking statins don't, and a new survey suggests that while not enough doctors are prescribing the cholesterol-lowering drugs, fears about side effects also play a part.
"There is so much misinformation about statins in the media that it's clearly permeated and now is affecting people's ability to take these medications and improve t...
MONDAY, March 18, 2019 (HealthDay News) --
Patients who have high triglycerides and take cholesterol-lowering statins to lower their risk for heart attack or stroke can cut that risk by another 30 percent by adding a high-dose omega-3 fatty acid pill, investigators report.
The prescription drug, called Vascepa, is not to be confused with over-the-counter dietary omega-3 (often...
Precious few treatment guidelines for heart patients are supported by the best scientific evidence, a new study shows.
Less than one in 10 recommendations are based on results from multiple randomized controlled trials (considered the "gold standard"), and that percentage has actually dropped in the past decade, the researchers reported.
People taking blood pressure medications have faced a frightening and bewildering series of pharmaceutical recalls in recent months, as trace amounts of cancer-causing chemicals have been discovered in individual batches of drugs.
But experts from the nation's leading heart groups are urging patients to remain calm, even as the recall list continues to grow.
Heart patients prescribed opioid painkillers when they leave the hospital may be less likely to get follow-up care and slightly more likely to die, a new study finds.
It included nearly 2,500 patients discharged from Vanderbilt University Medical Center in Nashville, Tenn., after treatment for heart attack, sudden heart failure or both between October 2011 and December 2015.
FRIDAY, Sept. 14, 2018 (HealthDay News) --
There's more bad news for Americans who took certain brands of the common blood pressure medication valsartan.
The U.S. Food and Drug Administration on Thursday warned that it has found a second impurity in three lots of Torrent Pharmaceuticals' valsartan drug products, which are used to treat both high blood pressure and heart failure.
After the U.S. Food and Drug Administration announced last week that certain brands of blood pressure medicines contained a carcinogen and were being recalled, many patients may wonder what's next for their cardiovascular care.
The FDA said it mandated the recall because valsartan medicines from a Chinese manufacturer, Zhejiang Huahai Pharmaceuticals, were found to contain N-nitrosodi...
As global warming heats up the planet, billions of people will need more air conditioning. And that could bring an uptick in serious health problems, a new study predicts.
The research estimates up to 1,000 more deaths annually in the eastern United States alone by 2050 -- deaths linked to rising levels of air pollution because more fossil fuels will be burned at power plants to meet...
When it comes to preventing heart disease, vitamin and mineral supplements are probably a waste of money, a new research review concludes.
The findings, published May 28 in the Journal of the American College of Cardiology, largely confirm what's already known: Supplements may be popular, but in most cases, there is no evidence they protect against heart disease.
One out of every three U.S. adults has high blood pressure that should be treated with medication, under guidelines recently adopted by the two leading heart health associations.
The American College of Cardiology and American Heart Association redefined high blood pressure at 130/80 in November, down from the previous level of 140/90, based on new evidence supporting a lower threshol...
People who've had a heart attack are more likely to be prescribed and take recommended blood-thinning drugs if they get vouchers to waive their co-payments, a new study shows.
The finding comes from a study of 11,000 people treated for heart attack at 300 U.S. hospitals. All of the patients had health insurance: 64 percent had private insurance, 42 percent were covered by Medicare and...
Preliminary research hints -- but cannot prove -- that men who lose their hair relatively early in life might be at heightened heart risk.
The study involved about 2,000 Indian men under 40 years of age. The researchers said that men who went prematurely gray and experienced male-pattern baldness at a young age had greatly increased odds for heart disease.